251 related articles for article (PubMed ID: 36431868)
1. Targeting DNA Topoisomerase II in Antifungal Chemotherapy.
Kondaka K; Gabriel I
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431868
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerases as anticancer targets.
Delgado JL; Hsieh CM; Chan NL; Hiasa H
Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
[TBL] [Abstract][Full Text] [Related]
3. DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs.
Shen LL; Baranowski J; Fostel J; Montgomery DA; Lartey PA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2778-84. PubMed ID: 1336349
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase as target for antibacterial and anticancer drug discovery.
Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of DNA topoisomerases I and II applied to Candida dubliniensis reduce growth, viability, the generation of petite mutants and toxicity, while acting synergistically with fluconazole.
Tagle-Olmedo T; Andrade-Pavón D; Martínez-Gamboa A; Gómez-García O; García-Sierra F; Hernández-Rodríguez C; Villa-Tanaca L
FEMS Yeast Res; 2021 Apr; 21(3):. PubMed ID: 33837766
[TBL] [Abstract][Full Text] [Related]
6. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
[TBL] [Abstract][Full Text] [Related]
9. DNA Topoisomerases as Targets for Antibacterial Agents.
Hiasa H
Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase I and II as targets for rational design of new anticancer drugs.
Cummings J; Smyth JF
Ann Oncol; 1993 Aug; 4(7):533-43. PubMed ID: 8395870
[TBL] [Abstract][Full Text] [Related]
11. Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors.
Jaswal S; Nehra B; Kumar S; Monga V
Bioorg Chem; 2020 Nov; 104():104266. PubMed ID: 33142421
[TBL] [Abstract][Full Text] [Related]
12. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
[TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
Pommier Y; Leo E; Zhang H; Marchand C
Chem Biol; 2010 May; 17(5):421-33. PubMed ID: 20534341
[TBL] [Abstract][Full Text] [Related]
14. A new 1-nitro-9-aminoacridine derivative targeting yeast topoisomerase II able to overcome fluconazole-resistance.
Rząd K; Paluszkiewicz E; Gabriel I
Bioorg Med Chem Lett; 2021 Mar; 35():127815. PubMed ID: 33486051
[TBL] [Abstract][Full Text] [Related]
15. Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.
Baglini E; Salerno S; Barresi E; Robello M; Da Settimo F; Taliani S; Marini AM
Eur J Pharm Sci; 2021 Jan; 156():105594. PubMed ID: 33059042
[TBL] [Abstract][Full Text] [Related]
16. 'Acridines' as New Horizons in Antifungal Treatment.
Gabriel I
Molecules; 2020 Mar; 25(7):. PubMed ID: 32218216
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of eupolauridine and its action on DNA topoisomerases.
Khan SI; Nimrod AC; Mehrpooya M; Nitiss JL; Walker LA; Clark AM
Antimicrob Agents Chemother; 2002 Jun; 46(6):1785-92. PubMed ID: 12019091
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy.
You F; Gao C
Curr Top Med Chem; 2019; 19(9):713-729. PubMed ID: 30931860
[TBL] [Abstract][Full Text] [Related]
19. Human deoxyribonucleic acid topoisomerases: molecular targets of anticancer drugs.
Holden JA
Ann Clin Lab Sci; 1997; 27(6):402-12. PubMed ID: 9433537
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation.
Shapiro AB; Austin CA
Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]